Structural Intervention

Category icon
Contemporary Management of Secondary Mitral Regurgitation

Kashish Goel, Colin M Barker, JoAnn Lindenfeld,

Category icon
Interatrial Shunting for Left Heart Failure

Leonardo Guimaraes, David del Val, Sebastien Bergeron, et al

Category icon
Antithrombotic Therapy After TAVI

Leslie Marisol Lugo, Rafael Romaguera, Joan Antoni Gómez-Hospital, et al

Category icon
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?

Mahmoud Abdelnabi, Abdallah Almaghraby, Yehia Saleh,

Category icon
Cardiovascular Management of Adults with Marfan Syndrome

Yukiko Isekame, Sabiha Gati, Jose Antonio Aragon-Martin, et al

Category icon
Risk Stratification in Asymptomatic Aortic Stenosis

Raluca Dulgheru, Sara Hana Weisz, Julien Magne, et al

Category icon
Transcatheter Aortic Valve Implantation in High-risk Patients with Severe…

Patricia Fonseca, Raphael Rosenhek, Vinayak Bapat, et al

Category icon
Embolic Protection

Jennifer Franke, Horst Sievert,

About

Valve replacement surgery can be an effective, lifesaving treatment option for people with aortic or mitral valve diseases.

Aortic valve replacement is often required in older patients but the surgical risk is often extremely high. Transcatheter aortic valve implantation (TAVI) is an established therapy for intermediate and high surgical risk patients with symptomatic severe aortic valve stenosis.

Approximately 1.8% of the US population has mitral valve disease, and an estimated 106,000 surgeries per year are for the treatment of valvular heart disease. The durability of surgical mitral valve repairs and replacement are limited. There is a 25% rate of significant mitral regurgitation recurrence in surgical repairs at 2 years and a 44% rate of primary valvular failure at 15 years, leaving the patient with either symptomatic mitral regurgitation, stenosis or both.

Related Articles

Articles

Article icon
Contemporary Management of Secondary Mitral Regurgitation

Kashish Goel, Colin M Barker, JoAnn Lindenfeld,

Published:

Citation: European Cardiology Review 2020;15:e22.

Interatrial Shunting for Left Heart Failure

Leonardo Guimaraes, David del Val, Sebastien Bergeron,

Published:

Citation: European Cardiology Review 2020;15:e18.

Antithrombotic Therapy After TAVI

Leslie Marisol Lugo, Rafael Romaguera, Joan Antoni Gómez-Hospital,

Published:

Citation: European Cardiology Review 2020;15:e09.

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?

Mahmoud Abdelnabi, Abdallah Almaghraby, Yehia Saleh,

Published:

Citation: European Cardiology Review 2020;15:e06.